These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 22720883

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Receptor binding enables botulinum neurotoxin B to sense low pH for translocation channel assembly.
    Sun S, Suresh S, Liu H, Tepp WH, Johnson EA, Edwardson JM, Chapman ER.
    Cell Host Microbe; 2011 Sep 15; 10(3):237-47. PubMed ID: 21925111
    [Abstract] [Full Text] [Related]

  • 3. Novel ganglioside-mediated entry of botulinum neurotoxin serotype D into neurons.
    Kroken AR, Karalewitz AP, Fu Z, Kim JJ, Barbieri JT.
    J Biol Chem; 2011 Jul 29; 286(30):26828-37. PubMed ID: 21632541
    [Abstract] [Full Text] [Related]

  • 4. Uptake of botulinum neurotoxin into cultured neurons.
    Keller JE, Cai F, Neale EA.
    Biochemistry; 2004 Jan 20; 43(2):526-32. PubMed ID: 14717608
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mechanism of botulinum neurotoxin B and G entry into hippocampal neurons.
    Dong M, Tepp WH, Liu H, Johnson EA, Chapman ER.
    J Cell Biol; 2007 Dec 31; 179(7):1511-22. PubMed ID: 18158333
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A Novel Inhibitor Prevents the Peripheral Neuroparalysis of Botulinum Neurotoxins.
    Azarnia Tehran D, Zanetti G, Leka O, Lista F, Fillo S, Binz T, Shone CC, Rossetto O, Montecucco C, Paradisi C, Mattarei A, Pirazzini M.
    Sci Rep; 2015 Dec 16; 5():17513. PubMed ID: 26670952
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Novel chimeras of botulinum neurotoxins A and E unveil contributions from the binding, translocation, and protease domains to their functional characteristics.
    Wang J, Meng J, Lawrence GW, Zurawski TH, Sasse A, Bodeker MO, Gilmore MA, Fernández-Salas E, Francis J, Steward LE, Aoki KR, Dolly JO.
    J Biol Chem; 2008 Jun 20; 283(25):16993-7002. PubMed ID: 18400760
    [Abstract] [Full Text] [Related]

  • 12. Botulinum neurotoxin D-C uses synaptotagmin I and II as receptors, and human synaptotagmin II is not an effective receptor for type B, D-C and G toxins.
    Peng L, Berntsson RP, Tepp WH, Pitkin RM, Johnson EA, Stenmark P, Dong M.
    J Cell Sci; 2012 Jul 01; 125(Pt 13):3233-42. PubMed ID: 22454523
    [Abstract] [Full Text] [Related]

  • 13. Structural basis of cell surface receptor recognition by botulinum neurotoxin B.
    Chai Q, Arndt JW, Dong M, Tepp WH, Johnson EA, Chapman ER, Stevens RC.
    Nature; 2006 Dec 21; 444(7122):1096-100. PubMed ID: 17167418
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Identification of a unique ganglioside binding loop within botulinum neurotoxins C and D-SA .
    Karalewitz AP, Kroken AR, Fu Z, Baldwin MR, Kim JJ, Barbieri JT.
    Biochemistry; 2010 Sep 21; 49(37):8117-26. PubMed ID: 20731382
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Synaptotagmin II and gangliosides bind independently with botulinum neurotoxin B but each restrains the other.
    Atassi MZ, Taruishi M, Naqvi M, Steward LE, Aoki KR.
    Protein J; 2014 Jun 21; 33(3):278-88. PubMed ID: 24740609
    [Abstract] [Full Text] [Related]

  • 18. Comparison of extracellular and intracellular potency of botulinum neurotoxins.
    Cai F, Adrion CB, Keller JE.
    Infect Immun; 2006 Oct 21; 74(10):5617-24. PubMed ID: 16988237
    [Abstract] [Full Text] [Related]

  • 19. Botulinum neurotoxins A and E undergo retrograde axonal transport in primary motor neurons.
    Restani L, Giribaldi F, Manich M, Bercsenyi K, Menendez G, Rossetto O, Caleo M, Schiavo G.
    PLoS Pathog; 2012 Dec 21; 8(12):e1003087. PubMed ID: 23300443
    [Abstract] [Full Text] [Related]

  • 20. Exchange of the H(CC) domain mediating double receptor recognition improves the pharmacodynamic properties of botulinum neurotoxin.
    Rummel A, Mahrhold S, Bigalke H, Binz T.
    FEBS J; 2011 Dec 21; 278(23):4506-15. PubMed ID: 21624052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.